Alan W. Dunton, Director of CorMedix CRMD, has filed 4 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $260K. The latest trade was on 01/26.

AD

AD

Alan W. Dunton

Director

Company

CorMedix CRMD

First filing

23/01/18

Trades

32 trades

Buys / sales

4 / 5

12-month net buying

−$260K

Last trade

01/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
CorMedixCRMD	Open-market sale10b5-1 plan	25/12/30	01/02	20,000 sh	$13.00	$260,000	−33.2%
CorMedixCRMD	Open-market sale	25/09/12	25/09/16	10,000 sh	$13.13	$131,300	−19.9%
Palatin TechnologiesPTN	Open-market buy	25/06/13	25/06/17	200 sh	$20,000.00	$4,000,000	+0.1%
OragenicsOGEN	Open-market sale	24/12/06	24/12/09	66 sh	$0.36	$23.76	−0.3%
CorMedixCRMD	Open-market buy	23/12/14–23/12/15	23/12/18	6,000 sh2 trades	$3.38avg.	$20,250	+64.9%
Palatin TechnologiesPTN	Open-market sale	23/12/04	23/12/06	200 sh2 trades	$2.48avg.	$495.98	−0.4%
CorMedixCRMD	Open-market buyAmendment	23/05/17	23/05/18	3,000 sh	$4.33	$12,990	+48.0%